Stocks · Korea 290650 KOSDAQ

L&c BIO

58,300원 +11.26% Market cap 1.6조 2026-10-07 close
Data as of 2026-10-07 · Linked from 7 pages
An overview for this page is not available in English yet. The figures below are updated daily.

Key figures 2026-10-07 basis

PER—
PBR7.41x
EPS0 KRW
BPS7,872 KRW
ROE-63.26%
DPS50 KRW

Returns and 52-week range

1W+21.47%
1M+18.72%
3M-28.31%
6M-14.89%
1Y+9.72%
YTD-4.53%
52W high121,064원
52W low40,823원
From 52W high-52.34%

Financial results (consolidated)

PeriodRevenueOperating incomeNet incomeOP margin
2022526억95억57억18.0%
2023689억77억485억11.2%
2024721억25억1,410억3.5%
2025855억44억-1,382억5.2%
Quarterly
2024 4Q191억-6억1,438억-3.3%
2025 1Q178억-4억-6억-2.4%
2025 2Q206억-2억-143억-1.2%
2025 3Q226억29억-513억12.8%
2025 4Q246억22억-720억8.9%
2026 1Q303억60억27억19.8%

Company

CEO이환철, 이재호 (각자 대표이사)
Founded2011-08-02
Fiscal year end12
Address: 경기도 성남시 중원구 둔촌대로 474, 605호, 606호, 607호 (선텍시티)

Peers in the same sector

CompanyMarket capP/EP/B1M
셀트리온제약1.8조45.834.07-1.84%
녹십자1.5조—1.22+2.76%
씨젠1.8조37.151.77+23.30%
오스코텍1.5조29.028.38+10.58%
에스티팜2.0조35.623.36-2.63%
대웅제약1.3조6.491.26-3.83%

Recent filings

Source: DART (Financial Supervisory Service electronic disclosure)

Recent news

Sources and notes

This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.